Tianjin Tianyao Pharmaceuticals (600488.SH): Injectable Methylprednisolone Sodium Succinate Obtains Registration Certificate from Panama Ministry of Health

Tianjin Tianyao Pharmaceuticals (600488.SH) announced that its subsidiary, JinYao Heping (Tianjin) Pharmaceutical Co., Ltd. (JinYao Heping), has obtained the registration certificate from the Ministry of Health of the Republic of Panama for the injection of methylprednisolone sodium succinate (signifying that the product can be produced and sold in the market of the Republic of Panama). Methylprednisolone sodium succinate injection is a type of glucocorticoid drug mainly used for anti-inflammatory treatment, immunosuppressive treatment, treatment of blood disorders and tumors, and treatment of shock, among other uses.